Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

FENC Fennec Pharmaceuticals Inc.

Market Closed 05-17 16:00:00 EDT

7.04

-0.08

-1.12%

盘后7.04

+0.000.00%

17:52 EDT

High7.09	Low6.70	Vol306.74K
Open7.03	D1 Closing7.12	Amplitude5.48%
Mkt Cap192.35M	Tradable Cap109.15M	Total Shares27.32M
T/O2.11M	T/O Rate1.98%	Tradable Shares15.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":7.04,"timestamp":1715976000000,"preClose":7.12,"halted":0,"volume":306739,"hourTrading":{"tag":"盘后","latestPrice":7.04,"preClose":7.04,"latestTime":"17:52 EDT","volume":1137,"amount":7989.4796,"timestamp":1715982773206},"delay":0,"floatShares":15504968,"shares":27322141,"eps":0.105081,"marketStatus":"Market Closed","change":-0.08,"latestTime":"05-17 16:00:00 EDT","open":7.03,"high":7.09,"low":6.7,"amount":2111720.413119,"amplitude":0.054775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.105081,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.12,"preHourTrading":{"tag":"盘前","latestPrice":7.05,"preClose":7.12,"latestTime":"09:29 EDT","volume":2108,"amount":14383.1614128,"timestamp":1715952599999},"postHourTrading":{"tag":"盘后","latestPrice":7.04,"preClose":7.04,"latestTime":"17:52 EDT","volume":1137,"amount":7989.4796,"timestamp":1715982773206},"volumeRatio":0.6191732192660336},"requestUrl":"/m/hq/s/FENC/wiki","defaultTab":"wiki","newsList":[{"id":"2435636179","title":"Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435636179","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435636179?lang=en_us&edition=fundamental","pubTime":"2024-05-15 19:20","pubTimestamp":1715772000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FENC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2024 07:20 ET (11:20 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2435549059","title":"JAN, MTC and PROK among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2435549059","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435549059?lang=en_us&edition=fundamental","pubTime":"2024-05-15 01:44","pubTimestamp":1715708682,"startTime":"0","endTime":"0","summary":"Gainers: Faraday Future Intelligent Electric  +308%. Cheetah Net Supply Chain Service  +236%. Crown ElectroKinetics Corp  +64%. Mmtec  +49%. Sunpower Corp  +47%. AMC Entertainment Holdings  +38%. Gamestop Corporation  +40%. Harrow  +35%. Delcath Systems  +34%.  ProKidney Corp  +33%.  Losers: Augmedix  -49%. Inotiv  -48%. Akoya Biosciences  -30%. Eastside Distilling  -28%. Virpax Pharmaceuticals  -29%. Fennec Pharmaceuticals  -26%. Shimmick Corp.  -26%. JanOne  -24%. Reborn Coffee  -23%. Nano Nuclear Energy  -17%.","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4106009-jan-mtc-and-prok-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2435514956","title":"Fennec Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2435514956","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435514956?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:22","pubTimestamp":1715696566,"startTime":"0","endTime":"0","summary":"* Fennec Pharmaceuticals Inc    reported quarterly adjusted earnings of 47 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -23 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435937511","title":"Cutera, Inotiv, Treace Medical Concepts among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2435937511","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435937511?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:00","pubTimestamp":1715695229,"startTime":"0","endTime":"0","summary":"Gainers: Harrow  +26%. Treace Medical Concepts  +25%. Syra Health  +23%. Delcath Systems  +21%. Cutera  +16%.  Losers: Inotiv  -55%. Augmedix  -54%. Akoya Biosciences  -26%. Fennec Pharmaceuticals  -21%. Durect  -20%.  S&P 500 Health Care Sector +0.18% to 1673.71. Health Care Equipment & Services +0.25% to 1937.37. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.26% to 1375.4.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4105844-cutera-inotiv-treace-medical-concepts-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2435462515","title":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435462515","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435462515?lang=en_us&edition=fundamental","pubTime":"2024-05-14 21:10","pubTimestamp":1715692213,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fennec Pharmaceuticals (FENC – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-biolife-solutions-blfs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-and-biolife-solutions-blfs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435515590","title":"Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) largest shareholders are individual investors who were rewarded as market cap surged US$25m last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2435515590","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2435515590?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:43","pubTimestamp":1715690599,"startTime":"0","endTime":"0","summary":"The considerable ownership by individual investors in Fennec Pharmaceuticals indicates that they collectively have a greater say in management and business strategy. 53% of the business is held by the top 7 shareholders. Every investor in Fennec Pharmaceuticals Inc.  should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 31% ownership. Put another way, the group faces the maximum upside potential .As a result, individual investors collectively scored the highest last week as the company hit US$274m market cap following a 10% gain in the stock.In the chart below, we zoom in on the different ownership groups of Fennec Pharmaceuticals.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate vie","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fennec-pharmaceuticals-inc-nasdaq-fenc-124319997.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435956065","title":"Fennec Pharmaceuticals Q1 2024 GAAP EPS $0.41 Beats $0.26 Estimate, Sales $25.377M Beat $18.876M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435956065","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435956065?lang=en_us&edition=fundamental","pubTime":"2024-05-14 18:27","pubTimestamp":1715682426,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.26 by 57.69 percent. This is a 278.26 percent increase over losses of $(0.23) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38810016/fennec-pharmaceuticals-q1-2024-gaap-eps-0-41-beats-0-26-estimate-sales-25-377m-beat-18-876m-estimat","is_publish_highlight":false,"gpt_icon":0},{"id":"2435939845","title":"Fennec Pharmaceuticals GAAP EPS of $0.41, revenue of $25.38M","url":"https://stock-news.laohu8.com/highlight/detail?id=2435939845","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435939845?lang=en_us&edition=fundamental","pubTime":"2024-05-14 18:10","pubTimestamp":1715681423,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals press release  (NASDAQ:FENC): Q1  GAAP EPS of $0.41.\nRevenue of $25.38M (+1410.7% Y/Y).","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4105641-fennec-pharmaceuticals-gaap-eps-of-0_41-revenue-of-25_38m","is_publish_highlight":false,"gpt_icon":0},{"id":"2435593357","title":"Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2435593357","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435593357?lang=en_us&edition=fundamental","pubTime":"2024-05-14 10:03","pubTimestamp":1715652180,"startTime":"0","endTime":"0","summary":"~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~  ~ Executed Exclusive Licensing Agreement ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/14/2881170/0/en/Fennec-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434836860","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836860","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434836860?lang=en_us&edition=fundamental","pubTime":"2024-05-10 18:00","pubTimestamp":1715335200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.i3 Verticals Inc. Class A                       2Q       .38       BMO","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2433789628","title":"Fennec Pharmaceuticals Inc    expected to post earnings of 26 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789628","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433789628?lang=en_us&edition=fundamental","pubTime":"2024-05-07 22:55","pubTimestamp":1715093748,"startTime":"0","endTime":"0","summary":"* Fennec Pharmaceuticals Inc     is expected to show a rise in quarterly revenue when it reports  results on May 9 (estimated) for the period ending March 31 2024   * The Research Triangle Park North ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433756378","title":"Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2433756378","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433756378?lang=en_us&edition=fundamental","pubTime":"2024-05-07 22:15","pubTimestamp":1715091300,"startTime":"0","endTime":"0","summary":"RESEARCH TRIANGLE PARK, N.C., May  07, 2024  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/07/2877343/0/en/Fennec-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-on-May-14-2024.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433413758","title":"Fennec Pharmaceuticals (FENC) Gets a Buy from Capital One Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2433413758","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2433413758?lang=en_us&edition=fundamental","pubTime":"2024-05-06 14:25","pubTimestamp":1714976737,"startTime":"0","endTime":"0","summary":"In a report released on May 2, Naureen Quibria from Capital One Financial reiterated a Buy rating on Fennec Pharmaceuticals (FENC – Research Report...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/fennec-pharmaceuticals-fenc-gets-a-buy-from-capital-one-financial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/fennec-pharmaceuticals-fenc-gets-a-buy-from-capital-one-financial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432998947","title":"Will Adherex Technologies Inc. (FENC) Report Negative Q1 Earnings? What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2432998947","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2432998947?lang=en_us&edition=fundamental","pubTime":"2024-05-02 22:01","pubTimestamp":1714658466,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when Adherex Technologies Inc.  reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over-year change of +82.6%.Revenues are expected to be $10.41 million, up 519.6% from the ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adherex-technologies-inc-fenc-report-140106578.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426149648","title":"Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426149648","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2426149648?lang=en_us&edition=fundamental","pubTime":"2024-04-10 01:53","pubTimestamp":1712685223,"startTime":"0","endTime":"0","summary":"When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. Long term Fennec Pharmaceuticals Inc.  shareholders would be well aware of this, since the stock is up 136% in five years. And in the last month, the share price has gained 12%. This could be related to the recent financial results that were recently released - you could check the most recent data by reading our company report.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.Get in touch with us directly. Alternatively, email","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/those-invested-fennec-pharmaceuticals-nasdaq-175343672.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425437845","title":"Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2425437845","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2425437845?lang=en_us&edition=fundamental","pubTime":"2024-04-06 07:00","pubTimestamp":1712358034,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Inc , a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction. According to a recent SEC Filing, the company's Chief Executive Officer, Rosty Raykov, sold 88,583 shares of the company on April 5, 2024.GuruFocus has detected 6 Warning Signs with FENC.Over the past year, the insider has sold a total of 157,867 shares of Fennec Pharmaceuticals Inc and has not made any purchases of the stock. This latest transaction continues a trend of insider sells at the company, with a total of 15 insider sells and no insider buys occurring over the past year.On the date of the reported sell, shares of Fennec Pharmaceuticals Inc were trading at $10.82 each, placing the company's market cap at approximately $294.225 million.The insider transaction history for Fennec Pharmaceuticals Inc suggests a pattern of insider sales that could be of in","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3IbQRuHSdx_5WGmXPMftzA--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/dee83afeb4e3c2e52b444fe180c1cfc5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3IbQRuHSdx_5WGmXPMftzA--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/dee83afeb4e3c2e52b444fe180c1cfc5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sell-ceo-rosty-raykov-230034324.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425553616","title":"Fennec Pharmaceuticals (NASDAQ:FENC) Price Target Raised to $18.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2425553616","media":"Defense World","top":-1,"share":"https://ttm.financial/m/news/2425553616?lang=en_us&edition=fundamental","pubTime":"2024-04-05 18:33","pubTimestamp":1712313218,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals (NASDAQ:FENC) Price Target Raised to $18.00","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmRlZmVuc2V3b3JsZC5uZXQvMjAyNC8wNC8wNS9mZW5uZWMtcGhhcm1hY2V1dGljYWxzLW5hc2RhcWZlbmMtcHJpY2UtdGFyZ2V0LXJhaXNlZC10by0xOC0wMC5odG1s0gEA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmRlZmVuc2V3b3JsZC5uZXQvMjAyNC8wNC8wNS9mZW5uZWMtcGhhcm1hY2V1dGljYWxzLW5hc2RhcWZlbmMtcHJpY2UtdGFyZ2V0LXJhaXNlZC10by0xOC0wMC5odG1s0gEA?oc=5","is_publish_highlight":false,"gpt_icon":0},{"id":"2424361064","title":"Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2424361064","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2424361064?lang=en_us&edition=fundamental","pubTime":"2024-04-04 18:32","pubTimestamp":1712226720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FENC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 04, 2024 06:32 ET (10:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2422975077","title":"Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422975077","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2422975077?lang=en_us&edition=fundamental","pubTime":"2024-03-28 07:00","pubTimestamp":1711580431,"startTime":"0","endTime":"0","summary":"Robert Andrade, the Chief Financial Officer of Fennec Pharmaceuticals Inc , has sold 13,975 shares of the company on March 26, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $10.9 per share, resulting in a total value of $152,327.5.GuruFocus has detected 4 Warning Signs with FENC.Fennec Pharmaceuticals Inc is a biopharmaceutical company focused on the development of PEDMARK , which is designed to reduce the incidence of hearing loss in pediatric cancer patients being treated with platinum-based chemotherapy. The company's commitment to addressing this significant unmet medical need is evident in its dedication to advancing PEDMARK through the clinical and regulatory process.Over the past year, the insider has sold a total of 82,950 shares of Fennec Pharmaceuticals Inc and has not made any purchases of the stock. This latest transaction continues the trend of insider sales at the company, with a total of 13 insider sells and no insider buys o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SH.hXTZzio0AeRoIHd8MtA--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/d13bccda43e92506a88ca50b573edcb7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SH.hXTZzio0AeRoIHd8MtA--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/d13bccda43e92506a88ca50b573edcb7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chief-financial-officer-robert-andrade-230031777.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422634654","title":"Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422634654","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2422634654?lang=en_us&edition=fundamental","pubTime":"2024-03-26 13:00","pubTimestamp":1711429240,"startTime":"0","endTime":"0","summary":"Robert Andrade, the Chief Financial Officer of Fennec Pharmaceuticals Inc , has sold 13,975 shares of the company on March 25, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $11 per share, which resulted in a total value of $153,725.GuruFocus has detected 3 Warning Signs with FENC.Fennec Pharmaceuticals Inc is a biopharmaceutical company focused on the development of PEDMARK , which is designed to reduce the incidence of hearing loss in pediatric cancer patients being treated with platinum-based chemotherapy.Over the past year, the insider has sold a total of 68,975 shares of Fennec Pharmaceuticals Inc and has not made any purchases of the stock. The recent sale by the insider is part of a series of transactions over the same period, which includes 11 insider sells and no insider buys.On the day of the insider's recent sale, shares of Fennec Pharmaceuticals Inc were trading at $11, giving the company a market capitalization of $301.594 milli","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3QLqcbvc1PwRtumBSfBQgw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/b1781fc10acaf831430b8f98631ccf95","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3QLqcbvc1PwRtumBSfBQgw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/b1781fc10acaf831430b8f98631ccf95"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chief-financial-officer-robert-andrade-050040876.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":-0.2779},{"period":"1month","weight":-0.2742},{"period":"3month","weight":-0.2186},{"period":"6month","weight":-0.1538},{"period":"1year","weight":-0.0512},{"period":"ytd","weight":-0.3725}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.027108},{"month":6,"riseRate":0.5,"avgChangeRate":0.038502},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026967},{"month":8,"riseRate":0.5,"avgChangeRate":-0.036198},{"month":9,"riseRate":0.666667,"avgChangeRate":0.058778},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012399},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.002651},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Fennec Pharmaceuticals Inc.(FENC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Fennec Pharmaceuticals Inc.(FENC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}